Highlights from the 22nd International AIDS Conference (AIDS 2018), 22-27 July 2018, Amsterdam, the Netherlands.

Christina K Psomas, Sarah Fidler, Malcolm Macartney, Richard Jeffreys, Lisa Reilly, Simon Collins, Santiago Moreno, Jean-Pierre Routy, Alexander Pasternak, Sabine Kinloch-de Loës

Abstract readEditorial

PubMed Full text at PMC

In one paragraph

Article in Journal of virus eradication, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.PloS one · 2019
Trial
Perceived benefits, challenges, and recommendations for HIV research dissemination and implementation science efforts in Tanzania: Findings from the HIV/AIDS Research Forum brainstorming session.PLOS global public health · 2022
Article
Antiretroviral Treatment Adherence Level and Associated Factors Among Adult HIV-Positive Patients on Both HIV/AIDS Care Models: Comparative Study in Selected Hospitals of Western Ethiopia, 2019.HIV/AIDS (Auckland, N.Z.) · 2021
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christina K PsomasDepartment of Infectious Diseases and Internal Medicine, European Hospital, Marseille, France.

Sarah FidlerImperial College London, London, UK.

Malcolm MacartneyJanssen, Pharmaceutical Companies of Johnson and Johnson. Canterbury, UK.

Richard JeffreysTreatment Action Group (TAG), USA.

Lisa Reilly, US Military HIV Research Program, Bethesda, MA, USA.

Simon CollinsHIV i-Base, London, UK.

Santiago MorenoRamon y Cajal Hospital, Madrid, Spain.

Jean-Pierre RoutyMcGill University Health Centre, Montreal, Canada.

Alexander PasternakDepartment of Medical Microbiology, Laboratory of Experimental Virology, AMC, Amsterdam, the Netherlands.

Sabine Kinloch-de LoësDepartment of Infection and Immunity, Royal Free Hospital and University College, London, UK.

Funding

Medical Research Council MR/L00528X/1

6 · The paper itself

Abstract

Important data on the social, epidemiological and clinical aspects of HIV-1, comorbidities and hepatitis as well as data on novel antiretroviral agents and the cure agenda were presented at AIDS 2018. This report covers some of the highlights.

Identifiers

PMID30515304

PMCPMC6248835

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.